Adjuvant comparison and characterization
Active Definitive Contract Awarded Last action
- Contract number
- 75N93022C00053
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,457,032
Award facts
- Opportunity
-
- Adjuvant Comparison and Characterization Pre-Solicitation · BAADAIT75N93020R00022 · Posted Mar 10, 2021
- Contract value 100% obligated
- $8,457,032.00 Current and potential, with all options
- Completion date 74% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27710, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $1,699,307 | |
| Change Order | $934,999 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $796,466 | |
| Change Order | $306,758 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,099,999 | |
| Change Order | $500,000 | |
| Exercise an Option | $1,099,999 | |
| Change Order | $722,690 | |
| Change Order | $196,814 | |
| Original award | $1,100,000 |
Show all 16
About this award
The National Institute of Allergy and Infectious Diseases awarded an $8.457 million definitive contract to Duke University for adjuvant comparison and characterization on September 1, 2022, under a cost-no-fee pricing structure with no set-aside.
The originating pre-solicitation, posted March 10, 2021, describes a multi-award program to compare adjuvants using vaccine and antigen platforms through comprehensive immune assessments, including omics and functional assays to establish immunological profiles of adjuvant strength, quality, breadth, and durability. Duke's scope includes developing and manufacturing formulations for test adjuvants, conducting in vitro assays, and performing in vivo immunogenicity studies, with performance through the university's Office of Research Administration Division in Durham, NC.
The contract runs through April 30, 2028. Subcontractors include Inimmune Corp, which supplies formulated adjuvant compounds and participates in biweekly project coordination, and the University of North Carolina at Chapel Hill, which performs in vivo mouse studies, human peripheral blood cell assays, and omics analysis on samples shipped from Duke.
Duke's SCI reporting shows actual government-invoiced labor of $734 thousand in FY2023 (2.7 FTEs, 5,610 contractor hours at $130.81 per hour), $1.8 million in FY2024 (1.1 FTEs, 2,323 contractor hours at $788.00 per hour), and $1.4 million in FY2025 (6.7 FTEs). Duke self-performed all reported hours across the measurement period with no subcontractor labor reported under SCI.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Inimmune Corp | $613,590 | |
| University Of North Carolina At Chapel Hill | $600,846 |
Quick answers
Who was awarded contract 75N93022C00053?
75N93022C00053 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2022.
How much is contract 75N93022C00053 worth?
The government has obligated $8,457,032 on 75N93022C00053.
Was contract 75N93022C00053 competed?
The extent of competition for 75N93022C00053 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award